10 /100
LOW RISK
Score updated Jul 13, 2026

ELAN — Elanco Animal Health Incorporated Dilution Risk Tracker

Track ELAN dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ELAN — Get alerts when the score changes →

As of July 13, 2026, Elanco Animal Health Incorporated (ELAN) has a DilutionWatch DilutionScore of 10/100, rated LOW dilution risk. Elanco Animal Health Incorporated has a market capitalization of $11.91B, 499.45M shares outstanding, 519 institutional holders tracked. Key dilution vectors include approximately 38 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
2
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for ELAN.
🔔 Track ELAN — Get forecast alerts →

💹 Market Data

Market Cap$11.91B
Shares Outstanding499.45M
Float494.84M
Cash$428.00M
Debt$4.39B
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 6.3% shares (2026Q1 vs prior)
519 institutional holders · 604.43M shares
#1 Dodge & Cox 68.94M shares
#2 FMR LLC 50.93M shares
#3 BlackRock, Inc. 47.62M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest35.22M
Days to Cover6.9
% of Float7.1%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for ELAN Shareholders

Elanco Animal Health Incorporated (ELAN) has a DilutionScore of 10/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for ELAN shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for ELAN in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ELAN alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track ELAN Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ELAN — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for ELAN
📊 ELAN FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 ELAN Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.